Physician profile
Robert Mccabe
NPI 1720508203
$1,946.39
in general payments reported to CMS, 2019-2025
13 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2021: $24.04 · 2022: $175 · 2023: $722 · 2024: $463 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,045 · Education: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,045.48 |
| Education | $299.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $509.98 | 2019-2023 | |
| Si-Bone, INC. | $285.40 | 2023-2024 | |
| Centinel Spine, LLC | $174.89 | 2022 | |
| Providence Medical Technology, INC. | $173.36 | 2023-2025 | |
| Stryker Corporation | $169.98 | 2019-2023 | Trevo |
| Medtronic USA, INC. | $148.50 | 2019 | |
| Integra Lifesciences Corporation | $135.00 | 2024 | Codman Certas, Cusa Clarity, Codman Hakim |
| Foundation Fusion Solutions, LLC | $129.35 | 2024 | |
| Abbott Laboratories | $91.34 | 2025 | Proclaim |
| Globus Medical, INC. | $40.01 | 2025 | Reline, Xtend, Sable |
| Boston Scientific Corporation | $36.53 | 2024 | |
| Alphatec Spine, INC | $28.01 | 2023 | Solus Alif |
| Medtronic, INC. | $24.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mccabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.